Hakeem Jeffries actually said...
The brand firms are actually filing these petitions, subsequently found to be almost always meritorious, and that results in the delay of lower cost generic drugs being brought to the market.
Context
Jeffries highlights how brand firms misuse petitions to delay generic drug entry.
04/28/2021